K. Schatteman
Publications by Year
Research Areas
Peptidase Inhibition and Analysis, Blood Coagulation and Thrombosis Mechanisms, Signaling Pathways in Disease, Diabetes Treatment and Management, Protease and Inhibitor Mechanisms
Most-Cited Works
- → Assay of Procarboxypeptidase U, a Novel Determinant of the Fibrinolytic Cascade, in Human Plasma(1999)80 cited
- → Proteolytic activation of purified human procarboxypeptidase U(2000)53 cited
- → Different mechanisms contribute to the biphasic pattern of carboxypeptidase U (TAFIa) generation during in vitro clot lysis in human plasma(2003)51 cited
- → Immunological Assay for the Determination of Procarboxypeptidase U Antigen Levels in Human Plasma(2001)49 cited
- → The Gene for Human Carboxypeptidase U (CPU)— A Proposed Novel Regulator of Plasminogen Activation— Maps to 13q14.11(1996)49 cited
- → Analysis of γ-hydroxybutyric acid, DL-lactic acid, glycolic acid, ethylene glycol and other glycols in body fluids by a direct injection gas chromatography-mass spectrometry assay for wide use(2004)37 cited
- → Activation of Plasma Procarboxypeptidase U in Different Mammalian Species Points to a Conserved Pathway of Inhibition of Fibrinolysis(1999)31 cited
- → Local proCPU (TAFI) Activation during Thrombolytic Treatment in a Dog Model of Coronary Artery Thrombosis can be Inhibited with a Direct, Small Molecule Thrombin Inhibitor (Melagatran)(2002)26 cited
- → Fast Homogeneous Assay for Plasma Procarboxypeptidase U(2001)20 cited
- → Subregional mapping of the human lymphocyte prolyl oligopeptidase gene (PREP) to human chromosome 6q22(1996)18 cited